相关实验视频
Updated: Jun 26, 2025
06:21
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
101
关于和其治疗的全面审查
V R RaviKKumar1, Sanjesh Rathi2, Shubham Singh3
1Professor and Head, Dept. of Pharmacognosy, The Erode College of Pharmacy, Perundurai Main Road, Veppampalayam, Erode-638112, Tamilnadu, India.
概括
胃潰瘍,胃或十二指腸內膜上的,主要是由H. pylori感染和NSAID使用引起的. 有效的管理需要多学科的方法,以获得更好的患者结果.
科学领域:
- 胃肠病学 胃肠病学
- 病理生理学 病理生理学
- 内部医学 内部医学
背景情况:
- 胃潰瘍疾病仍然是全球主要的健康問題,造成嚴重的罹病率和死亡率.
- 胃肠道和十二指肠道代表了严重的胃病的形式.
- 的形成涉及攻击性因素 (例如,盐酸,素,白血,活性氧物种) 和保护机制 (例如,粘液屏障,前列腺素,粘膜血液流动) 之间的不平衡.
研究的目的:
- 审查病理生理学和胃潰瘍疾病的主要原因.
- 要突出Helicobacter pylori感染和非类固醇抗炎药物 (NSAID) 使用的关键作用.
- 强调需要一个多学科的策略来管理胃潰瘍.
主要方法:
- 关于胃潰瘍疾病的文献综述.
- 对病因因素和病原机制的分析.
- 综合当前关于管理的理解.
主要成果:
- 确定了盐酸 (HCL),素,白血 (LT) 和活性氧物种 (ROS) 作为主要的攻击性因素.
- 已承认粘液-碳酸盐屏障,前列腺素 (PG),粘膜血液流动和细胞再生是关键的保护元素.
- 确认H. pylori感染和NSAID使用是导致胃潰瘍疾病的主要原因.
结论:
- 胃潰瘍疾病的病變是多因素的,涉及進攻和防御性粘膜因子的複雜相互作用.
- 感染H. pylori和使用NSAID是主要的病因因子.
- 一种全面的,多学科的方法对于优化胃潰瘍的管理和提高患者的生活质量至关重要.
相关概念视频
01:26Peptic Ulcer Disease IV: Management
89
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
89
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
297
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
297
01:30Peptic Ulcer Disease I: Introduction
164
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
164
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
371
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
371
01:28Peptic Ulcer Disease II: Pathophysiology
399
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
399
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
414
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
414